This inventor holds 3 USPTO granted patents. Top assignees: Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Gmbh. Active years: 1986-1988.
Company Filing History:
2 out of 278 
1 out of 306 
Years Active: 1986-1988
Introduction
Edward L. Barsumian is a distinguished inventor based in Danbury, Connecticut, recognized for his contributions to the pharmaceutical industry. With a total of three patents to his name, he has significantly impacted the field with his innovative solutions.
Latest Patents
Among Edward's notable inventions, his latest patents include:
1. **Bis(piperazinyl or homopiperazinyl)alkanes**: This patent covers compounds of a specific formula where various substitutions are possible, including hydrogen, alkyl groups, hydroxyl, and others, which are critical in the development of pharmaceuticals.
2. **Substituted phenylalkylhomopiperazinylpropyl ureas or thioureas**: These compounds demonstrate noteworthy activity as antihistamines and as inhibitors of mediator release from basophils or mast cells. This invention has implications in treating allergic reactions and other related conditions.
Career Highlights
Edward has had a fruitful career, primarily working with Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim GmbH. His work at these prestigious organizations has allowed him to focus on drug development and innovation in therapeutic agents.
Collaborations
Throughout his career, Edward has collaborated with several notable professionals, including John P. Devlin and Karl D. Hargrave. These collaborations have enriched his work and fostered an environment of shared innovation.
Conclusion
Edward L. Barsumian has made significant strides in the field of pharmaceutical inventions. With his innovative patents and collaborative spirit, he continues to contribute to advancements in medicine, making notable impacts in treating various health conditions. His journey illustrates the vital role inventors play in shaping the future of healthcare.